Dr. Katherina Siewert, head of Dermatotoxicology Study Centre, BfR, Berlin, Germany. Dr. Siewert studied biochemistry at the Universities of Potsdam and Lund with a focus on immunology. During her doctoral thesis at the Max-Planck-Institute of Neurobiology, Martinsried, she developed a new method for the unbiased identification of antigens for CD8+ T cells, which was awarded the prize of the Novartis Foundation for Therapeutic Research in 2011. Subsequently, the method was successfully applied to identify a psoriasis autoantigen during a postdoc at the Ludwig Maximilian University of Munich. Since 2012, Dr. Siewert has been studying chemical-specific T cell responses, developing activation-induced marker assays at the BfR. Her expertise includes the analysis of allergen-specific T cell receptor repertoires, antigen binding sites, and T cell cross-reactivity. Dr. Siewert is a member of various professional societies like the German Society for Immunology (DGfI), the European Society of Contact Dermatitis (ESCD) and the German Contact Allergy Group (DKG).